Skip to main content
Caplight Logo









CollPlant Biotechnologies Ltd.

CollPlant Biotechnologies Ltd.

Public
IsraelHealthcarehttps://collplant.com/

CollPlant Biotechnologies Ltd. is now publicly traded

The data on this page reflects CollPlant Biotechnologies Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jul 20, 2026

Total Funding Raised

$10.4M

Company Overview

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company that develops products based on its proprietary recombinant human collagen (rhCollagen) for 3D bioprinting of tissues and organs, medical aesthetics, and advanced wound care.

Sector

Healthcare

AI Layer

Non-AI

Keywords

recombinant human collagenrhCollagen3D bioprintingbioprintingbioinkregenerative medicinetissue engineeringbiomaterialsmedical aestheticssoft tissue repairbiotechlab grown tissuebioprinting inksynthetic biologyorgan manufacturing

CollPlant Biotechnologies Ltd. Comparables

Compare CollPlant Biotechnologies Ltd. with similar companies based on industry and business-model similarity.

CollPlant Biotechnologies Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

CollPlant Biotechnologies Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementJul 20, 2026

Key People

Founding team and executive leadership

Eran Rotem

Deputy CEO Chief Financial Officer

Executive Team

Oded Shoseyov

Chief Scientific Officer at CollPlant, Chief Scientific Officer

Executive Team

CollPlant Biotechnologies Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CollPlant Biotechnologies Ltd. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersIsrael
Employee Range56
Year Founded2004
Last FundingJul 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?